12:00 AM
 | 
Nov 17, 2008
 |  BC Week In Review  |  Company News  |  Deals

Daiichi Sankyo, Ranbaxy deal

Daiichi increased its stake in Ranbaxy from 52.5% to 63.9% by completing the previously announced acquisition of 130 million shares...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >